Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether Uses, Dosage, Side Effects, Food Interaction and all others data.
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).
| Trade Name | Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether |
| Generic | Dihematoporphyrin ether |
| Dihematoporphyrin ether Other Names | bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether, DHP ether, Dihematoporphyrin ether |
| Type | |
| Formula | C68H74N8O11 |
| Weight | Average: 1179.385 Monoisotopic: 1178.547705235 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether
